Edith de Boer is the HR Director for Zimmer Biomet in Australia and New Zealand. Her career originally was in telecommunications and consulting in Europe. After leaving The Netherlands, Edith worked into the Australian medical research industry, before moving into a human resources role at Zimmer Biomet. Edith spoke to Australian Health Journal about her role and the organisation.
Promoting medical technology as an industry is important for Zimmer Biomet. The organisation runs a program called “Your future in STEM” helping girls at high school children consider STEM as a career, through to career professionals in the “Women-Inspired Network” or WIN as it’s commonly referred to. In clinical professions, the Zimmer Biomet “Women in Orthopaedics” program for female surgeons, acts in an advocate and support role.
Collaboration and work mindset of one team is very important for the organisation, as well as employees having a sense of belonging and being included. So whilst, talent can be difficult to find in the current market, Zimmer Biomet staff are together taking a journey of change that’s occurring across the industry.
Upbeat Edith’s energy is refreshing! Anyone looking to enter the medical technology industry and specifically the humans resources role can make a difference to people’s lives. Her advice? Be creative, work hard and have a growth mindset.
-
Handling modern day diets and misinformation as a HCP
Laureate Professor Clare Collins AO in Nutrition and Dietetics at the University of Newcastle, emphasises the need for accurate and reliable nutrition information to reach the public. Prof Collins believes that it is vital for clinicians to stay up-to-date with cutting-edge nutrition science and work with communication organisations to disseminate information to the general public. This is particularly important as social media is full of both reliable and unreliable information on dietary patterns, such as veganism.
-
Value of MedTech Report brings Industry and Government together
In June 2023 the Medical Technology Association of Australia (MTAA) launched The Value of MedTech Report – a major study quantifying the difference the MedTech industry makes to the lives of Australian patients, the healthcare system and the Australian economy.
Australian Health Journal spoke with MTAA CEO, Ian Burgess and MTAA Policy Manager, Pravin Siriwardena about the report and its key findings.
-
Maximising benefits, minimising harms in population health screening
Population screening is an important contributor to advancing health outcomes through the early detection of and successful intervention for chronic disease. The evolution of science, technology and evidence relating to diseases which are or may be amenable to a population screening approach deserve broad discussion and the sharing of expertise and evidence. They also warrant close scrutiny in context of health policy and health resource allocation considerations.
In March, Public Health Association of Australia (PHAA) convened Screening Conference Conference 2025 with the theme of ‘Population Screening for Chronic Disease – Maximising Benefits, Minimising Harms’.
